Marie Lindner

Marie Lindner is a seasoned professional in the biotechnology and life sciences sectors, currently serving as a Board Director for Hanimune and a Board Member at Orthogon Therapeutics. With extensive experience as an Investment Committee member at BioCurate Pty Ltd and President of BioValue Creation, LLC, Marie offers strategic advice and insights. Previous roles include Independent Director on the Scientific Advisory Board at FutuRx, Independent Board Director for giiant pharma inc., Global Program Head at Novartis, and Senior Director at Shire Pharmaceuticals. Marie's academic background includes an MD from Chicago Medical School and a BA in Biology from Washington University in St. Louis.